EVOQ Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- EVOQ Therapeutics's estimated annual revenue is currently $1.7M per year.
- EVOQ Therapeutics's estimated revenue per employee is $155,000
Employee Data
- EVOQ Therapeutics has 11 Employees.
- EVOQ Therapeutics grew their employee count by 0% last year.
EVOQ Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Co-Founder and CSO | Reveal Email/Phone |
3 | Co-Founder and VP Preclinical Development | Reveal Email/Phone |
4 | COO | Reveal Email/Phone |
5 | Director, Development & Program Management | Reveal Email/Phone |
6 | Senior Director Production and Quality | Reveal Email/Phone |
7 | Senior Scientist, Quality Control | Reveal Email/Phone |
EVOQ Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $1.9M | 12 | 0% | N/A | N/A |
#2 | $3.2M | 41 | -56% | $31.2M | N/A |
#3 | $0.9M | 6 | 20% | N/A | N/A |
#4 | $2.2M | 29 | 93% | N/A | N/A |
#5 | $6.2M | 40 | 3% | N/A | N/A |
#6 | $5.4M | 35 | 35% | N/A | N/A |
#7 | $2M | 13 | 8% | N/A | N/A |
#8 | $0.6M | 4 | -20% | N/A | N/A |
#9 | $13M | 84 | -11% | N/A | N/A |
#10 | $4.2M | 27 | 4% | N/A | N/A |
What Is EVOQ Therapeutics?
EVOQ Therapeutics is developing immunotherapies to improve the lives of individuals fighting autoimmune diseases.\n\nThere are more than 100 chronic autoimmune diseases - many severely debilitating, and some life-threatening. According to the National Institutes of Health, up to 23.5 million Americans (over 7% of the population) suffer from autoimmune disease, and the prevalence is rising.\n\nAutoimmune disease occurs when the body’s central immune tolerance system fails - resulting in T and B cell-mediated destruction of self-tissues. This immune system failure is responsible for many devastating diseases including – Type 1 Diabetes, Celiac disease, Multiple sclerosis and Rheumatoid Arthritis.\n\nEVOQ’s technology unleashes and restores the body’s natural immune tolerance pathways.
keywords:N/A
N/A
Total Funding
11
Number of Employees
$1.7M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Ann Arbor
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3.2M | 11 | 1000% | N/A |
#2 | $1M | 11 | 22% | N/A |
#3 | $1M | 11 | 10% | N/A |
#4 | $0.9M | 11 | -50% | N/A |
#5 | $1M | 11 | 38% | N/A |